4-164969678-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001012414.3(TRIM61):āc.325C>Gā(p.Gln109Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00013 ( 0 hom., cov: 30)
Exomes š: 0.00014 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
TRIM61
NM_001012414.3 missense
NM_001012414.3 missense
Scores
19
Clinical Significance
Conservation
PhyloP100: -1.23
Genes affected
TRIM61 (HGNC:24339): (tripartite motif containing 61) Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in innate immune response; protein ubiquitination; and regulation of gene expression. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.025644153).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TRIM61 | NM_001414904.1 | c.325C>G | p.Gln109Glu | missense_variant | 3/3 | ENST00000710271.1 | |
TRIM61 | NM_001012414.3 | c.325C>G | p.Gln109Glu | missense_variant | 3/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TRIM61 | ENST00000710271.1 | c.325C>G | p.Gln109Glu | missense_variant | 3/3 | NM_001414904.1 | P1 | ||
TRIM61 | ENST00000329314.6 | c.325C>G | p.Gln109Glu | missense_variant | 3/5 | 1 | |||
TRIM61 | ENST00000508856.2 | c.325C>G | p.Gln109Glu | missense_variant | 3/3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 19AN: 150730Hom.: 0 Cov.: 30 FAILED QC
GnomAD3 genomes
AF:
AC:
19
AN:
150730
Hom.:
Cov.:
30
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000102 AC: 18AN: 176228Hom.: 0 AF XY: 0.000127 AC XY: 12AN XY: 94258
GnomAD3 exomes
AF:
AC:
18
AN:
176228
Hom.:
AF XY:
AC XY:
12
AN XY:
94258
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.000140 AC: 197AN: 1406768Hom.: 0 Cov.: 26 AF XY: 0.000142 AC XY: 100AN XY: 702304
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
197
AN:
1406768
Hom.:
Cov.:
26
AF XY:
AC XY:
100
AN XY:
702304
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.000126 AC: 19AN: 150730Hom.: 0 Cov.: 30 AF XY: 0.000123 AC XY: 9AN XY: 73418
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
19
AN:
150730
Hom.:
Cov.:
30
AF XY:
AC XY:
9
AN XY:
73418
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
9
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 04, 2022 | The c.325C>G (p.Q109E) alteration is located in exon 3 (coding exon 1) of the TRIM61 gene. This alteration results from a C to G substitution at nucleotide position 325, causing the glutamine (Q) at amino acid position 109 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
MutationTaster
Benign
N
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MutPred
Gain of loop (P = 0.069);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at